SIRS-Lab Overview

  • Founded
  • 2000
  • Status
  • Acquired/​Merged
  • Employees
  • 30
  • Latest Deal Type
  • M&A

SIRS-Lab General Information


Developer of diagnostic technology for deadly infections. The company specializes in detecting blood poisoning and sepsis, and to determine the causative agent while monitoring speficic immuno responses for treatment information.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Other Pharmaceuticals and Biotechnology
Primary Office
  • Otto-Schott-Straße 15
  • 07745 Jena
  • Germany
+49 03641 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SIRS-Lab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-May-2013 Completed Bankruptcy: Admin/Reorg
3. Bankruptcy: Admin/Reorg 01-Jan-2013 Completed Bankruptcy: Admin/Reorg
2. Later Stage VC (Series A) 14-Dec-2006 $13.1M $33.4M Completed Product Development
1. Early Stage VC $20.3M $20.3M Completed Product Development
To view SIRS-Lab’s complete valuation and funding history, request access »

SIRS-Lab Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SIRS-Lab Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Affentranger Associates Venture Capital Minority 000 0000 000000 0
bm-t Beteiligungsmanagement Thuringen Venture Capital Minority 000 0000 000000 0
To view SIRS-Lab’s complete investors history, request access »